Allergy
Omalizumab Dose-Related Efficacy in a Cohort of Children With Severe Food Allergy: OSAFA Observational Study.
Stefania Arasi, Carol Bitetti, Lucia Lo Scalzo, Alessandra Spagnoli, Elena Fabrizi, Alessandro Fiocchi, Arianna Cafarotti
Published: 202610.1111/all.70228
Abstract
BACKGROUND: We recently published on the clinical efficacy of a 1-year-long evaluation of 65 asthmatics with severe IgE-mediated food allergy (FA) under Omalizumab: Omalizumab is safe and able to increase reactivity threshold, allows safe food introd…
Preview only. Read the full abstract at the source